These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18957878)

  • 1. Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar.
    Welsh P; Packard CJ; Sattar N
    Curr Opin Lipidol; 2008 Dec; 19(6):563-71. PubMed ID: 18957878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?
    Rubin C; Nolin TD; Himmelfarb J
    Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):506-11. PubMed ID: 18089962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on integrated biomarkers for assessment of long-term risk of cardiovascular complications in initially healthy subjects and patients with manifest atherosclerosis.
    Koenig W
    Ann Med; 2009; 41(5):332-43. PubMed ID: 19291518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New cardiovascular risk factors exist, but are they clinically useful?
    Wang TJ
    Eur Heart J; 2008 Feb; 29(4):441-4. PubMed ID: 18276617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for cardiovascular disease: challenges and future directions.
    May A; Wang TJ
    Trends Mol Med; 2008 Jun; 14(6):261-7. PubMed ID: 18487087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide.
    McGeechan K; Macaskill P; Irwig L; Liew G; Wong TY
    Arch Intern Med; 2008 Nov; 168(21):2304-10. PubMed ID: 19029492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for atherosclerosis: pathophysiological role and pharmacological modulation.
    Ferri N; Paoletti R; Corsini A
    Curr Opin Lipidol; 2006 Oct; 17(5):495-501. PubMed ID: 16960497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease.
    Herder C; Karakas M; Koenig W
    Clin Pharmacol Ther; 2011 Jul; 90(1):52-66. PubMed ID: 21654741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do novel biomarkers add to existing scores of total cardiovascular risk?
    De Backer G; Graham I; Cooney MT
    Eur J Prev Cardiol; 2012 Aug; 19(2 Suppl):14-7. PubMed ID: 22801065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of biomarkers in the management of patients with acute coronary syndromes.
    O'Donoghue M; Morrow DA
    Curr Opin Cardiol; 2008 Jul; 23(4):309-14. PubMed ID: 18520713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin.
    May A; Wang TJ
    Expert Rev Mol Diagn; 2007 Nov; 7(6):793-804. PubMed ID: 18020909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of biomarkers for risk stratification of cardiovascular events using genetic algorithm with recursive local floating search.
    Zhou X; Wang H; Wang J; Wang Y; Hoehn G; Azok J; Brennan ML; Hazen SL; Li K; Chang SF; Wong ST
    Proteomics; 2009 Apr; 9(8):2286-94. PubMed ID: 19337989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for pediatric urological disease.
    Lee RS
    Curr Opin Urol; 2009 Jul; 19(4):397-401. PubMed ID: 19440151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New biomarkers for cardiovascular risk evaluation].
    Chironi G
    Rev Prat; 2012 Jun; 62(6):783-5. PubMed ID: 22838270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing and assessing cardiovascular biomarkers.
    Dadu RT; Nambi V; Ballantyne CM
    Transl Res; 2012 Apr; 159(4):265-76. PubMed ID: 22424430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in peripheral arterial disease.
    Thomas JC; Vohra RS; Beer S; Bhatti K; Ponnambalam S; Homer-Vanniasinkam S
    Trends Cardiovasc Med; 2009 Jul; 19(5):147-51. PubMed ID: 20005473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating biomarkers.
    Badimon L; Romero JC; Cubedo J; Borrell-Pagès M
    Thromb Res; 2012 Oct; 130 Suppl 1():S12-5. PubMed ID: 23026650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does fibrinogen add to prediction of cardiovascular disease? Results from the Scottish Heart Health Extended Cohort Study.
    Woodward M; Tunstall-Pedoe H; Rumley A; Lowe GD
    Br J Haematol; 2009 Aug; 146(4):442-6. PubMed ID: 19549268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of cardiovascular risk prediction: time to review current knowledge, debates, and fundamentals on how to assess test characteristics.
    Romanens M; Ackermann F; Spence JD; Darioli R; Rodondi N; Corti R; Noll G; Schwenkglenks M; Pencina M
    Eur J Cardiovasc Prev Rehabil; 2010 Feb; 17(1):18-23. PubMed ID: 19952758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.